Expression of Diazepam-Binding Inhibitor Peptide in Human Skin: An Immunohistochemical and Ultrastructural Study
- 1 December 1993
- journal article
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 101 (6) , 800-803
- https://doi.org/10.1111/1523-1747.ep12371698
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- The role of diazepam binding inhibitor and its processing products at mitochondrial benzodiazepine receptors: Regulation of steroid biosynthesisNeuropharmacology, 1991
- Modulation of insulin secretion by diazepam binding inhibitor and its processing productsNeuropharmacology, 1991
- “Prolegomena” to the biology of the diazepam binding inhibitor (DBI)Neuropharmacology, 1991
- Acyl-CoA-binding and transport, an alternative function for diazepam binding inhibitor (DBI), which is identical with acyl-CoA-binding proteinNeuropharmacology, 1991
- Immunohistochemistry of diazepam binding inhibitor (DBI) in the central nervous system and peripheral organs: Its possible role as an endogenous regulator of different types of benzodiazepine receptorsNeuropharmacology, 1991
- Diazepam binding inhibitor (DBI): A peptide with multiple biological actionsLife Sciences, 1991
- Biology of sweat glands and their disorders. I. Normal sweat gland functionJournal of the American Academy of Dermatology, 1989
- A diazepam binding inhibitor (DBI)-like neuropeptide is detected in human brainBrain Research, 1986
- Benzodiazepine Receptor-Mediated Chemotaxis of Human MonocytesScience, 1985
- Diazepam-Binding Inhibitor: A Neuropeptide Located in Selected Neuronal Populations of Rat BrainScience, 1985